v3.26.1
Stock-Based Compensation (Tables)
 12 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-based Compensation Expense The Company recognized stock-based compensation expense in the following line items on the Consolidated Statements of Operations for the fiscal years ended March 31, 2026, 2025, and 2024:
(Amounts in thousands)202620252024
Cost of goods sold$6,926 $5,232 $4,708 
Selling, general and administrative expenses25,42821,34927,278
Total stock-based compensation expense$32,354 $26,581 $31,986 
The following table summarizes stock-based compensation expense by award type for the fiscal years ended March 31, 2026, 2025, and 2024:
(Amounts in thousands)202620252024
Stock options$6,831 $5,944 $5,287 
Restricted stock12,27510,4037,991
Performance-based restricted stock units9,4406,58615,459
Employee Stock Purchase Plan2,0791,7361,056
Non-employee director restricted stock1,7291,9122,193
Total stock-based compensation expense$32,354 $26,581 $31,986 
Summary of Assumption Used in Estimate Fair Value of Stock Options The following table summarizes the assumptions used in estimating the fair value of stock options:
 202620252024
Common stock price$119.30 $177.38 $96.51
Expected stock price volatility46.7% 45.5% 45.6%
Risk-free interest rate4.2% 4.5% 3.8%
Weighted-average expected life (years)6.0 6.0 6.0
Dividend yield0.60% 0.36% 0.58%
Schedule of Stock Option Activity
The stock option activity for the fiscal year ended March 31, 2026 is summarized as follows:
(Share amounts in thousands)
Number
of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (in years)
Outstanding at beginning of year871$67.95 5.4
Granted132119.37—
Exercised(139)46.91—
Forfeited(12)133.54—
Outstanding at end of year85278.455.3
Vested at end of year62159.724.1
Unvested at end of year231128.771.7
Fair value of options granted during the year$56.74 
The stock option activity for the fiscal year ended March 31, 2026 is summarized as follows:
2013 Plan
(Share amounts in thousands)
Number
of Shares
Weighted Average Exercise PriceWeighted Average Remaining Contractual Term (in years)
Outstanding at beginning of year13$24.20 1.0
Granted———
Exercised(13)24.20—
Forfeited———
Outstanding at end of year———
Vested at end of year———
Unvested at end of year—$— — 
Summary of Unvested Restricted Stock Grants
Restricted Stock - The information about the unvested restricted stock grants as of March 31, 2026 is as follows:
(Share amounts in thousands)
Number
of Shares
 
Weighted Average
Grant Date Fair Value
Unvested at beginning of year199$135.82 
Granted135124.02
Vested(100)124.54
Forfeited(12)134.56
Unvested at end of year222$133.76 
Summary of Performance Units Granted
Performance-based Restricted Units (“Performance units”) - The information about the performance units granted under the 2017 Omnibus Plan is as follows:
(Share amounts in thousands)
Number
of Shares
 
Weighted Average Grant Date Fair Value
Unvested at beginning of year209$122.33 
Granted97147.39
Added by Performance Factor2699.29
Vested(85)100.61
Forfeited(9)131.21
Unvested at end of year238$137.35